EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Allosteric Modulation of Pathological Ataxin‐3 Aggregation: A Path to Spinocerebellar Ataxia Type‐3 Therapies

Alexandra Silva iD, Sara Duarte-Silva iD, Pedro M Martins iD, Beatriz Rodrigues, Débora Serrenho iD, Daniela Vilasboas-Campos, Andreia Teixeira-Castro iD, Julio Vieyto-Nuñez iD, Joel Mieres-Perez iD, Francisco Figueiredo iD, Martyna Podlasiak iD, Tatiana Van-der-Kellen und 17 weitere

Advanced Science · 2025

DOI: 10.1002/advs.202502216 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Alexandra Silva und 28 weiteren Autor:innen. Beteiligte Einrichtung: i3S -Institute for Research and Innovation in Health, Institute for Molecular and Cellular Biology (IBMC), Porto University, Porto, 4200-150, Portuga…. Hauptthemen laut MEDLINE: Ataxin-3, Machado-Joseph Disease, Protein Aggregation, Pathological. Die Arbeit nennt 108 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: U.S. Department of Energy, Fundação para a Ciência e a Tecnologia, Ataxia-UK, Ataxia-UK, AISA (Associazione Italiana per la lotta alle Sindromi Atassiche), ACAH (Catalan Association of Hereditary Ataxias), Swedish SCA-network,….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Spinocerebellar ataxia type 3 (SCA3) is a rare neurodegenerative disorder caused by the expansion of a polyglutamine (polyQ) repeat in ataxin‐3 (Atx3) for which no disease‐modifying therapies are available. The presence of protein inclusions enriched in polyQ‐expanded Atx3 in neurons suggests that inhibiting its self‐assembly may provide targeted therapies. Here, it is demonstrated that the supramolecular tweezer CLR01 binds to a lysine residue on a positively charged patch of the Atx3 catalytic Josephin domain, decreasing conformational fluctuations of the distal helical hairpin, without altering its ubiquitin hydrolase activity. This reduces exposure of the aggregation‐prone region that initiates Atx3 self‐assembly, ultimately delaying Atx3 amyloid fibril formation and reducing the secondary nucleation rate, a process linked to fibril proliferation and toxicity. CLR01's effects translate into the reversal of synapse loss in SCA3 cultured cortical neuron model, improve locomotor function in a Caenorhabditis elegans SCA3 model, and delay disease onset with reduced severity of motor symptoms in a SCA3 mouse model. These insights reveal a novel allosteric site for developing CLR01‐inspired therapies targeting pathological aggregation while preserving essential functional sites. They also highlight that targeting allosteric sites in amyloid‐forming proteins may provide new opportunities for safe therapeutic strategies for various protein misfolding disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ataxin-3Machado-Joseph DiseaseProtein Aggregation, PathologicalAnimalsCaenorhabditis elegansHumansMiceDisease Models, AnimalAllosteric RegulationNeuronsProtein AggregatesRepressor Proteins

Stichwörter der Autor:innen

amyloidmolecular therapiesmolecular tweezerpolyglutaminepreclinical modelsprotein dynamics

Substanzen

Ataxin-3Protein AggregatesATXN3 protein, humanRepressor Proteins

Autor:innen und Institutionen

  • i3S -Institute for Research and Innovation in Health, Institute for Molecular and Cellular Biology (IBMC), Porto University, Porto, 4200-150, Portugal.
  • Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, ICVS/3B's, PT Government Associate Laboratory, Braga, 4710-057, Portugal.
  • Center for Neuroscience and Cell Biology (CNC-UC) & Center for Innovative Biomedicine and Biotechnology (CIBB), University of Coimbra, Coimbra, 3004-504, Portugal.
  • Institute for Interdisciplinary Research, University of Coimbra, Coimbra, 3004-504, Portugal.
  • Department of Biochemical and Chemical Engineering, TU Dortmund University, 44227, Dortmund, Germany.
  • King's College London, London, WC2R 2LS, UK.

ORCID-Profile: Alexandra Silva, Sara Duarte-Silva, Pedro M Martins, Débora Serrenho, Andreia Teixeira-Castro, Julio Vieyto-Nuñez, Joel Mieres-Perez, Francisco Figueiredo, Martyna Podlasiak, Joana Fraga, Ana Luísa Carvalho, Patrícia Maciel, Sandra Macedo-Ribeiro

Förderung

  • U.S. Department of Energy
  • Fundação para a Ciência e a Tecnologia
  • Ataxia-UK, Ataxia-UK, AISA (Associazione Italiana per la lotta alle Sindromi Atassiche), ACAH (Catalan Association of Hereditary Ataxias), Swedish SCA-network,…
  • Foundation for the National Institutes of Health
  • Deutsche Forschungsgemeinschaft
  • H2020 Spreading Excellence and Widening Participation
  • NIGMS NIH HHS
  • National Ataxia Foundation

Zitieren

APA

Silva, A., Duarte-Silva, S., Martins, P. M., Rodrigues, B., Serrenho, D., Vilasboas-Campos, D., Teixeira-Castro, A., Vieyto-Nuñez, J., Mieres-Perez, J., Figueiredo, F., Podlasiak, M., Van-der-Kellen, T., Fraga, J., Noble, J., Lantz, C., Sepanj, N., Monteiro-Fernandes, D., Guerreiro, S., Neves-Carvalho, A., …, & Macedo-Ribeiro, S. (2025). Allosteric Modulation of Pathological Ataxin‐3 Aggregation: A Path to Spinocerebellar Ataxia Type‐3 Therapies. Advanced Science. https://doi.org/10.1002/advs.202502216

Vancouver

Silva A, Duarte-Silva S, Martins PM, Rodrigues B, Serrenho D, Vilasboas-Campos D, et al. Allosteric Modulation of Pathological Ataxin‐3 Aggregation: A Path to Spinocerebellar Ataxia Type‐3 Therapies. Advanced Science. 2025. doi:10.1002/advs.202502216

BibTeX
@article{Silva2025,
  author = {Silva, Alexandra and Duarte-Silva, Sara and Martins, Pedro M and Rodrigues, Beatriz and Serrenho, Débora and Vilasboas-Campos, Daniela and Teixeira-Castro, Andreia and Vieyto-Nuñez, Julio and Mieres-Perez, Joel and Figueiredo, Francisco and Podlasiak, Martyna and Van-der-Kellen, Tatiana and Fraga, Joana and Noble, James and Lantz, Carter and Sepanj, Niki and Monteiro-Fernandes, Daniela and Guerreiro, Sara and Neves-Carvalho, Andreia and Pereira-Sousa, Joana and Klärner, Frank-Gerrit and Schrader, Thomas and Loo, Joseph A and Pastore, Annalisa and Sanchez-Garcia, Elsa and Bitan, Gal and Carvalho, Ana Luísa and Maciel, Patrícia and Macedo-Ribeiro, Sandra},
  title = {Allosteric Modulation of Pathological Ataxin‐3 Aggregation: A Path to Spinocerebellar Ataxia Type‐3 Therapies},
  journal = {Advanced Science},
  year = {2025},
  doi = {10.1002/advs.202502216}
}
Kostenlos starten →